Virus parainfluenza de type 5 : Questions médicales fréquentes
Nom anglais: Parainfluenza Virus 5
Descriptor UI:D045402
Tree Number:B04.820.480.937.600.650.750.800
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus parainfluenza de type 5 : Questions médicales les plus fréquentes",
"headline": "Virus parainfluenza de type 5 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus parainfluenza de type 5 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus parainfluenza de type 5"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Rubulavirus",
"url": "https://questionsmedicales.fr/mesh/D019213",
"about": {
"@type": "MedicalCondition",
"name": "Rubulavirus",
"code": {
"@type": "MedicalCode",
"code": "D019213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.937.600.650.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus parainfluenza de type 5",
"alternateName": "Parainfluenza Virus 5",
"code": {
"@type": "MedicalCode",
"code": "D045402",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Biao He",
"url": "https://questionsmedicales.fr/author/Biao%20He",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States of America."
}
},
{
"@type": "Person",
"name": "Keisuke Ohta",
"url": "https://questionsmedicales.fr/author/Keisuke%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."
}
},
{
"@type": "Person",
"name": "Machiko Nishio",
"url": "https://questionsmedicales.fr/author/Machiko%20Nishio",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: mnishio@wakayama-med.ac.jp."
}
},
{
"@type": "Person",
"name": "Yusuke Matsumoto",
"url": "https://questionsmedicales.fr/author/Yusuke%20Matsumoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Fiscal austerity and municipal health spending: an interrupted time series study.",
"datePublished": "2024-09-23",
"url": "https://questionsmedicales.fr/article/39319934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.11606/s1518-8787.2024058005772"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advancing health information during interhospital transfer: An interrupted time series.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37846028",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jhm.13221"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis.",
"datePublished": "2024-09-30",
"url": "https://questionsmedicales.fr/article/39347841",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10916-024-02113-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of COVID-19 lock down on teenage pregnancies in Northern Uganda: an interrupted time series analysis.",
"datePublished": "2023-11-04",
"url": "https://questionsmedicales.fr/article/37925395",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12978-023-01707-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Eviction filings during bans on enforcement throughout the COVID-19 pandemic: an interrupted time series analysis.",
"datePublished": "2023-08-15",
"url": "https://questionsmedicales.fr/article/37581748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-023-00813-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN de polarité négative",
"item": "https://questionsmedicales.fr/mesh/D000086103"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mononegavirales",
"item": "https://questionsmedicales.fr/mesh/D018096"
},
{
"@type": "ListItem",
"position": 6,
"name": "Paramyxoviridae",
"item": "https://questionsmedicales.fr/mesh/D010252"
},
{
"@type": "ListItem",
"position": 7,
"name": "Paramyxovirinae",
"item": "https://questionsmedicales.fr/mesh/D018098"
},
{
"@type": "ListItem",
"position": 8,
"name": "Rubulavirus",
"item": "https://questionsmedicales.fr/mesh/D019213"
},
{
"@type": "ListItem",
"position": 9,
"name": "Virus parainfluenza de type 5",
"item": "https://questionsmedicales.fr/mesh/D045402"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus parainfluenza de type 5 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus parainfluenza de type 5",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus parainfluenza de type 5",
"description": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?\nQuels tests sont utilisés pour confirmer le virus parainfluenza 5 ?\nLes symptômes aident-ils au diagnostic du virus parainfluenza 5 ?\nPeut-on diagnostiquer le virus parainfluenza 5 par sérologie ?\nLes radiographies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus parainfluenza de type 5",
"description": "Quels sont les symptômes courants du virus parainfluenza 5 ?\nLe virus parainfluenza 5 cause-t-il des complications respiratoires ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes persistent-ils longtemps ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus parainfluenza de type 5",
"description": "Comment prévenir l'infection par le virus parainfluenza 5 ?\nLes vaccins protègent-ils contre ce virus ?\nFaut-il éviter les lieux publics en cas d'épidémie ?\nLe port de masque est-il utile ?\nLes enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus parainfluenza de type 5",
"description": "Quel est le traitement principal pour le virus parainfluenza 5 ?\nDes antiviraux sont-ils efficaces contre ce virus ?\nQuand faut-il consulter un médecin ?\nLes inhalateurs sont-ils recommandés ?\nLe repos est-il important lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus parainfluenza de type 5",
"description": "Quelles sont les complications possibles du virus parainfluenza 5 ?\nLes personnes âgées sont-elles plus à risque de complications ?\nLe virus peut-il aggraver des maladies préexistantes ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications si elles surviennent ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus parainfluenza de type 5",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes maladies respiratoires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes nourrissons sont-ils plus à risque ?\nLes conditions de vie affectent-elles le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, cultures virales et des analyses cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le virus parainfluenza 5 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures de prélèvements respiratoires sont les plus courants."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic du virus parainfluenza 5 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la toux et la fièvre orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus parainfluenza 5 par sérologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sérologie n'est pas couramment utilisée pour ce virus, les tests PCR sont préférés."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les radiographies peuvent montrer des signes d'infection, mais ne confirment pas le virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus parainfluenza 5 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, congestion nasale et difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Le virus parainfluenza 5 cause-t-il des complications respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme la bronchite ou la pneumonie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez la détresse respiratoire et la fièvre élevée, surtout chez les enfants."
}
},
{
"@type": "Question",
"name": "Les symptômes persistent-ils longtemps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent durer de quelques jours à deux semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus parainfluenza 5 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lavez-vous les mains régulièrement et évitez le contact avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre ce virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin spécifique contre le virus parainfluenza 5 actuellement."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les lieux publics en cas d'épidémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les lieux bondés peut réduire le risque de transmission du virus."
}
},
{
"@type": "Question",
"name": "Le port de masque est-il utile ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut aider à réduire la propagation des infections respiratoires."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre d'autres virus comme la grippe est recommandée."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus parainfluenza 5 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, incluant des antipyrétiques et des bronchodilatateurs."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils efficaces contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour le virus parainfluenza 5."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes s'aggravent ou si la respiration devient difficile."
}
},
{
"@type": "Question",
"name": "Les inhalateurs sont-ils recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les inhalateurs peuvent aider à soulager la respiration en cas de bronchospasme."
}
},
{
"@type": "Question",
"name": "Le repos est-il important lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos aide le corps à combattre l'infection et à récupérer plus rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus parainfluenza 5 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la bronchite, la pneumonie et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Le virus peut-il aggraver des maladies préexistantes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aggraver des maladies respiratoires chroniques comme l'asthme."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications si elles surviennent ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent une hospitalisation et un traitement médical intensif."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque."
}
},
{
"@type": "Question",
"name": "Les maladies respiratoires augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents de maladies respiratoires sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque d'infections respiratoires, y compris parainfluenza."
}
},
{
"@type": "Question",
"name": "Les nourrissons sont-ils plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nourrissons ont un système immunitaire immature, les rendant plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des environnements surpeuplés ou insalubres augmente le risque d'infection."
}
}
]
}
]
}
To analyze the impact of the fiscal austerity policy (PAF) on health spending in Brazilian municipalities, considering population size and source of funds....
The interrupted time series method was used to analyze the effect of the PAF on total expenditure, resources transferred by the Federal Government, and own/state per capita resources allocated to heal...
The results for the national average of municipalities show that the PAF had a negative impact on the level of total expenditure and own/state resources allocated to health in the first half of 2015, ...
In general, the impact of the PAF on health financing in municipalities was immediate and based on the decrease in own/state resources allocated to health. In large municipalities, however, the impact...
Although the transfer of patients between acute care hospitals (interhospital transfer, IHT) is common, health information exchange (HIE) during IHT remains inadequate, with fragmented communication a...
Study subjects include patients aged >18 transferred to the medical, cardiology, oncology, or intensive care unit (ICU) services at an 800-bed quaternary care hospital; and healthcare workers involved...
We will track patient safety endpoints and clinician workflow burdens and ensure the protection of patient data throughout the study. We will disseminate our findings via the creation of a toolkit for...
Fixed and broad screening intervals for drug-drug interaction (DDI) alerts lead to false positive alerts, thereby contributing to alert fatigue among healthcare professionals. Hence, we aimed to inves...
Pregnancy and childbirth complications are the leading cause of death among girls aged 15-19 years globally, with low- and middle-income countries (LMICs) accounting for 99% of global maternal deaths ...
Using interrupted time series analysis (ITS), sometimes known as quasi-experimental time series analysis. We constructed a time series of the first ANC service utilization records for girls aged 10-19...
The teenage pregnancy trend before the lockdown was decreasing by - 0.203 pregnancies per month, but in the first month after the institution of the lockdown (March 20, 2020), there was an increase in...
Teenage pregnancies increased during the lockdown. This slight increase depicted the impact of the pandemic on the teenage pregnancy trend associated with the COVID-19 outbreak. The government needs t...
Bans on evictions were implemented to reduce the spread of COVID-19 and to protect vulnerable populations during a public health crisis. Our objective was to examine how three bans on eviction enforce...
Data were derived from eviction application records kept by the Ontario Landlord and Tenant Board. We used segmented regression analysis to model changes in the average weekly filing rates for evictio...
The average number of weekly L1 and L2 applications dropped by 67.5 (95% CI: 55.2, 79.9) and 31.7 (95% CI: 26.7, 36.6) filings per 100,000 rental dwellings, respectively, following the first ban on ev...
Our findings suggest that while the first ban on eviction enforcement appeared to substantially reduce filing rates, subsequent bans were less effective and none of them eliminated eviction filings al...
Epidemics are anticipated to influence the coverage of health services. We assessed the impact of the COVID-19 pandemic on maternal healthcare indices and care providers' performance....
1801 maternal healthcare centres under the auspices of Shiraz University of Medical Sciences, Shiraz, Southern Iran....
Approximately 63 000 pregnant women....
In this prospective ecological study, interrupted time series analysis was used to model and compare the trend of maternal healthcare indices before and after the COVID-19 pandemic announcement....
The results showed a significant drop in count of preconception healthcare visits, first routine laboratory tests, first trimester prenatal care, first trimester sonography, prenatal screening for bir...
Using ecological data during the COVID-19 pandemic era, we observed a 'level change and slope change' as the major pattern of interruption of maternal healthcare coverage, indicating a possible indire...
In 2016, China initiated the merge of the urban resident basic medical insurance scheme and new rural cooperative medical scheme into one unified health insurance scheme: the urban and rural resident ...
Data published early in the COVID-19 pandemic suggested that smokers infected with SARS-CoV-2 were more likely to need hospital treatment or die than non-smokers, and thus this was seen as a motivator...
Interrupted time series analysis to investigate the impact of COVID-19, and the shift to remote delivery of smoking cessation support, on the number of smokers who accessed cessation support with LLBD...
11,393 episodes of smoking cessation support were opened with LLBD between 01 January 2018 and 31 December 2021. The weekly count of all outcomes was increasing prior to the date when LLBD converted t...
The COVID-19 pandemic, and associated shift to remote delivery of smoking cessation support by LLBD, had no substantial sustained overall impact on measures of smoking cessation service activity and s...
Preliminary evidence from China and other countries has suggested that coronavirus disease 2019 (COVID-19) mitigation measures have caused a decline in preterm births, but evidence is conflicting. Uti...
To prevent tobacco use in Korea, the national quitline number was added to tobacco packages in December 2012, tobacco prices were raised by 80% in January 2015, and graphic health warning labels were ...
Monthly mortality from suicide was obtained from Cause-of-Death Statistics in Korea from December 2007 to December 2019. Interrupted time-series analysis was performed using segmented Poisson regressi...
Suicide mortality was 20 per 1,000,000 in December 2007 and showed a downward trend over the study period. After the implementation of tobacco packaging and pricing policies, suicide mortality immedia...
The findings of this study provide new evidence for an association between tobacco control policies and deaths by suicide. An array of effective tobacco control policies should be considered for preve...